1. cannabidiol (CBD), at a dose greater than 300 mg / day, in combination with standard antiepileptic agent (SAED), acting through the sodium or calcium channels, for use in treating epilepsii.2. Use of cannabidiol (CBD), at a dose greater than 300 mg / day, in combination with standard antiepileptic agent (SAED), acting through the sodium or calcium channels, for the manufacture of a medicament for use in treating epilepsii.3. Cannabidiol (CBD) CBD or the use of claim 1 or 2, wherein SAED is a drug which: - changes the low-threshold or neuronal calcium transients flows or- reduces high-frequency neuronal activity and sodium-dependent action potentials and enhances the action of GABA .4. Cannabidiol (CBD) CBD or the use of claim 1 or 2, wherein SAED selected from the group consisting of ethosuximide and valproata.5. Cannabidiol (CBD) CBD or the use of claim 1 or 2, wherein the type of epilepsy to be treated is a generalized attack or attack temporal doli.6. Cannabidiol (CBD) CBD or the use of claim 1 or 2, wherein the type of epilepsy to be treated is unresponsive to conventional circuit lecheniya.7. Cannabidiol (CBD) CBD or the use of claim 1 or 2, wherein the CBD is used with one or more other therapeutically effective fitokannabinoidami.8. Cannabidiol (CBD) CBD or the use of claim 7, wherein one or more other therapeutically effective fitokannabinoidov represent THCV and / or CBDV.9. Cannabidiol (CBD) CBD or use according to any one of claims 1 or 2, wherein the CBD is a dedicated fitokannabinoid.10. Cannabidiol (CBD) CBD or use according to any one of claims 1 or 2, wherein the pre CBD1. Каннабидиол (CBD), в дозе большей, чем 300 мг/день, в комбинации со стандартным противоэпилептическим средством (SAED), действующим посредством натриевых или кальциевых каналов, для применения в лечении эпилепсии.2. Применение каннабидиола (CBD), в дозе большей, чем 300 мг/день, в комбинации со стандартным противоэпилептическим средством (SAED), действующим посредством натриевых
